Overexpression of protein phosphatase 2A in a murine model of chronic myocardial infarction leads to increased adverse remodeling but restores the regulation of β-catenin by glycogen synthase kinase 3β
Abstract
Background/objectives Increased activity of cardiac protein phosphatases is an important feature in human heart failure. Several different protein phosphatases (PP) are involved in the regulation of excitation-contraction-coupling of the myocardium. Protein phosphatase 2A (PP2A) is a serine/threonine phosphatase consisting of a dimeric core enzyme and tissue-specific subunits. In this study we used transgenic mice overexpressing PP2A to further investigate the role of PP2A in cardiac remodeling after myocardial infarction.Methods and results Adult male CD-1 mice overexpressing the catalytic subunit α of PP2A (αMHC-PP2A; TG) underwent chronic LAD-ligation or sham surgery, respectively; wildtype littermates (WT) were used as controls. Cardiac function was determined by echocardiography before and 28 days after LAD-ligation. 28 days after MI, the animals were sacrificed and cardiac remodeling was analyzed in histological sections and by Western blots. PP2A overexpression leads to dilated cardiomyopathy in mice, and increased cardiomyocyte hypertrophy and fibrosis of the remote myocardium can be seen after myocardial infarction. However, we found an improved survival of TG in the subacute phase after MI in comparison to WT. On the molecular level, TG shows reduced expression of SERCA and CaMKII alpha both under basal condition as well 28 days after MI. Additionally, the regulation of the Akt/GSK3β/β-catenin pathway is severely disturbed in TG at baseline where a significant activation of Akt is found that coincides with the typical phosphorylation of GSK3β. However, this does not lead to the accumulation of β-catenin - on the contrary: phosphorylation-induced degradation of β-catenin is significantly enhanced.Conclusion Transgenic overexpression of myocardial PP2A causes adverse remodeling which coincides with a disruption of the classical Akt/GSK3/β-catenin pathway under baseline conditions that is restored to normal values in chronic myocardial infarction. Even so overall survival of TG after myocardial infarction was not constrained and survival after day 2 post MI was improved.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Cα transgenic mice showed increased AKT and GSK-3β phosphorylation and increased β-catenin degradation.
“Conversely, increased AKT and GSK-3β phosphorylation, and increased β-catenin degradation were seen in the Cα transgenic mice [63].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [63]
This increased infarct size was not associated with decreased survival and unexpectedly improved survival in the subacute phase after infarction, potentially due to restoration of normal AKT and GSK-3β phosphorylation and β-catenin levels.
“This was however not associated with a decreased survival, and unexpectedly, even resulted in improved survival in the subacute phase after infarction -potentially, because upon myocardial infarction, restoration of normal AKT and GSK-3β phosphorylation, and β-catenin levels could be noted [63].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [63]
Chronic myocardial infarction in Cα transgenic mice increased left ventricle infarct size, suggesting impaired post-myocardial infarction remodeling capacity.
“an increased left ventricle infarct size was observed, suggestive for impaired post-myocardial infarction remodeling capacity.”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [63]
The observed decline in phospholamban phosphorylation, possibly due to reduced CaMKIIα expression or increased PP2A activity, could reinforce SERCA inhibition and further exacerbate the phenotype.
“the observed decline in PLB phosphorylation, possibly subsequent to reduced CaMKIIα expression or increased PP2A activity, could reinforce its inhibition of SERCA, further exacerbating the phenotype [63].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [63]
RyR2 Ser2808 hypophosphorylation was also seen in the cardiac Ppp2ca overexpression model, co-occurring with reductions in CaMKIIα and SERCA protein expression.
“RyR 2 Ser2808 hypophosphorylation was also seen in the Ppp2ca cardiac overexpression model, co-occurring with reductions of CaMKIIα and sarcoplasmic reticulum Ca 2+ -ATPase (SERCA) protein expression [63].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [63]
Cites
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568 · see citing works
Wnt/β-catenin signaling and disease
Clevers, H., & Nusse, R. (2012) · Cell · doi:10.1016/j.cell.2012.05.012 · Cited by 5,554 · see citing works
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325 · see citing works
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530417 · Cited by 1,890 · see citing works
Regulation of cardiac hypertrophy by intracellular signalling pathways
Heineke, J., & Molkentin, J. D. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1983 · Cited by 1,856 · see citing works
Cohen, P., & Frame, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096075 · Cited by 1,478 · see citing works
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/bj3530417 · Cited by 1,392 · see citing works
Progressive hypertrophy and heart failure in β 1 -adrenergic receptor transgenic mice
Engelhardt, S. H., Hein, L., Wiesmann, F., & Lohse, M. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.7059 · Cited by 784 · see citing works
Huber, A. H., & Weis, W. I. (2001) · Cell · doi:10.1016/s0092-8674(01)00330-0 · Cited by 777 · see citing works
Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional Activity*
Fang, D.-X., Hawke, D., Zheng, Y., Xia, Y., Meisenhelder, J., Nika, H., Mills, G., Kobayashi, R., Hunter, T., & Lu, Z. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611871200 · Cited by 774 · see citing works
Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo
Antos, C. L., McKinsey, T. A., Frey, N., Kutschke, W. J., McAnally, J., Shelton, J. M., Richardson, J. A., Hill, J. A., & Olson, E. N. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231619298 · Cited by 477 · see citing works
Phosphorylation of β-Catenin by Cyclic AMP-dependent Protein Kinase
Taurin, S., Sandbo, N. K., Qin, Y., Browning, D. D., & Dulin, N. O. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m508778200 · Cited by 450 · see citing works
Tong, H., Imahashi, K., Steenbergen, C., & Murphy, E. (2002) · Circulation Research · doi:10.1161/01.res.0000012567.95445.55 · Cited by 377 · see citing works
Phospholamban: A Prominent Regulator of Myocardial Contractility
Koss, K. L., & Kranias, E. G. (1996) · Circulation Research · doi:10.1161/01.res.79.6.1059 · Cited by 355 · see citing works
Nairn, A. C., & Palfrey, H. C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45377-x · Cited by 341 · see citing works
Wnt-induced dephosphorylation of Axin releases beta -catenin from the Axin complexPreprint
Willert, K., Shibamoto, S., & Nusse, R. (1999) · Genes & Development · doi:10.1101/gad.13.14.1768 · Cited by 337 · see citing works
Schwinger, R. H. G., Münch, G., Bölck, B., Karczewski, P., Krause, E., & Erdmann, E. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0897 · Cited by 287 · see citing works
Effects of Serine/Threonine Protein Phosphatases on Ion Channels in Excitable Membranes
Herzig, S., & Neumann, J. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.1.173 · Cited by 270 · see citing works
Increased Expression of Cardiac Phosphatases in Patients with End-stage Heart Failure
Neumann, J., Thomas Eschenhagen, A., Jones, L. R., Linck, B., Schmitz, W. L., Scholz, H., & Zimmermann, N. (1997) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1996.0271 · Cited by 263 · see citing works
Type 1 Phosphatase, a Negative Regulator of Cardiac Function
Carr, A. N., Schmidt, A. G., Suzuki, Y., del Monte, F., Sato, Y., Lannér, C., Breeden, K., Jing, S.-L., Allen, P. B., Greengard, P., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.12.4124-4135.2002 · Cited by 259 · see citing works
Zhang, T., Johnson, E. N., Gu, Y., Morissette, M. R., Sah, V. P., Gigena, M. S., Belke, D. D., DILLMANN, W. H., Rogers, T. B., Schulman, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108525200 · Cited by 245 · see citing works
Stabilization of β-catenin by a Wnt-independent mechanism regulates cardiomyocyte growth
Haq, S., Michael, A., Andreucci, M., Bhattacharya, K., Dotto, G. P., Walters, B. M., Woodgett, J. R., Kilter, H., & Force, T. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0835895100 · Cited by 227 · see citing works
Casein kinase I phosphorylates and destabilizes the β-catenin degradation complex
Gao, Z.-H., Seeling, J. M., Hill, V., Yochum, A., & Virshup, D. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032468199 · Cited by 225 · see citing works
Ikeda, S., Kishida, M., Matsuura, Y., Usui, H., & Kikuchi, A. (2000) · Oncogene · doi:10.1038/sj.onc.1203359 · Cited by 175 · see citing works
APC Is Essential for Targeting Phosphorylated β-Catenin to the SCFβ-TrCP Ubiquitin Ligase
Su, Y., Fu, C., Ishikawa, S., Stella, A., Kojima, M., Shitoh, K., Schreiber, E. M., Day, B. W., & Liu, B. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.10.023 · Cited by 174 · see citing works
Zakhary, D. R., Moravec, C. S., Stewart, R. W., & Bond, M. (1999) · Circulation · doi:10.1161/01.cir.99.4.505 · Cited by 146 · see citing works
β-Catenin Downregulation Is Required for Adaptive Cardiac Remodeling
Baurand, A., Zelarayan, L. C., Betney, R., Gehrke, C., Dunger, S., Noack, C., Busjahn, A., Huelsken, J., Taketo, M. M., Birchmeier, W., et al. (2007) · Circulation Research · doi:10.1161/01.res.0000266605.63681.5a · Cited by 138 · see citing works
Zelarayan, L. C., Noack, C., Sekkali, B., Kmecova, J., Gehrke, C., Renger, A., Zafeiriou, M.-P., van der Nagel, R., Dietz, R., Windt, L. J. D., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808393105 · Cited by 129 · see citing works
Overexpression of the catalytic subunit of protein phosphatase 2A impairs cardiac function
Gergs, U., Boknik, P., Buchwalow, I., Fabritz, L., Matus, M., Justus, I., Hanske, G., Schmitz, W., & Neumann, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405770200 · Cited by 125 · see citing works
Hahn, J., Cho, H.-J., Bae, J.-W., Yuk, H.-S., Kim, K., Park, K. W., Koo, B.-K., Chae, I., Shin, C.-S., Oh, B., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603916200 · Cited by 122 · see citing works
Ebelt, H., Jungblut, M., Zhang, Y., Kubin, T., Sawa Kostin, D., Technau, A., Oustanina, S., Niebruegge, S., Lehmann, J., Werdan, K., et al. (2006) · Stem Cells · doi:10.1634/stemcells.2006-0374 · Cited by 111 · see citing works
Zhao, J., Yue, W., Zhu, M. J., Sreejayan, N., & Du, . (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.03.161 · Cited by 90 · see citing works
Weinbrenner, C., Baines, C. P., Liu, G.-S., Armstrong, S. C., Ganote, C. E., Walsh, A. H., Honkanen, R. E., Cohen, M. V., & Downey, J. M. (1998) · Circulation · doi:10.1161/01.cir.98.9.899 · Cited by 82 · see citing works
Protein phosphatase activity is increased in a rat model of long-term β-adrenergic stimulation
Boknı́k, P., Fockenbrock, M., Herzig, S., Knapp, J., Linck, B., Lüss, H., Müller, F. U., Müller, T., Schmitz, W. L., Schröder, F., et al. (2000) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002100000283 · Cited by 81 · see citing works
Activity of protein phosphatases against initiation factor-2 and elongation factor-2
Redpath, N. T., & Proud, C. G. (1990) · Biochemical Journal · doi:10.1042/bj2720175 · Cited by 80 · see citing works
Regional expression of phospholamban in the human heart
Boknı́k, P. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00053-x · Cited by 66 · see citing works
Distinct functions of Wnt/β-catenin signaling in KV development and cardiac asymmetry
Lin, X., & Xu, X. (2008) · Development · doi:10.1242/dev.029561 · Cited by 65 · see citing works
Effects of Regulatory Subunits on the Kinetics of Protein Phosphatase 2A
Price, N. E., & Mumby, M. C. (2000) · Biochemistry · doi:10.1021/bi0008478 · Cited by 57 · see citing works
Altered phosphatase activity in heart failure, influence on Ca 2+ movement
Neumann, J. (2002) · Basic Research in Cardiology · doi:10.1007/s003950200036 · Cited by 56 · see citing works
Hirschy, A., Croquelois, A., Perriard, E. R., Schoenauer, R., Agarkova, I., Hoerstrup, S. P., Taketo, M. M., Pedrazzini, T., Perriard, J., & Ehler, E. (2010) · Basic Research in Cardiology · doi:10.1007/s00395-010-0101-8 · Cited by 50 · see citing works
Angiotensin II regulates phosphorylation of translation elongation factor-2 in cardiac myocytes
Everett, A. D., Stoops, T. D., Nairn, A. C., & Brautigan, D. L. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.1.h161 · Cited by 46 · see citing works
Dilated cardiomyopathy in transgenic mice expressing a mutant A subunit of protein phosphatase 2A
Brewis, N., Ohst, K., Fields, K., Rapacciuolo, A., Chou, D., Bloor, C., Dillmann, W., Rockman, H., & Walter, G. (2000) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2000.279.3.h1307 · Cited by 46 · see citing works
Evaluating the Role of Wnt Signal Transduction in Promoting the Development of the Heart
Eisenberg, L. M., & Eisenberg, C. A. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.71 · Cited by 40 · see citing works
Deshmukh, P. A., Blunt, B. C., & Hofmann, P. A. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00225.2006 · Cited by 32 · see citing works
In-Vivo Electrophysiological Study in Mice with Chronic Anterior Myocardial Infarction
Korte, T., Fuchs, M., Guener, Z., Bonin, J. V., de Sousa, M., Niehaus, M., Tebbenjohanns, J., & Drexler, H. (2002) · Journal of Interventional Cardiac Electrophysiology · doi:10.1023/a:1015359332161 · Cited by 29 · see citing works
Microvascular endothelial cells remodel cultured adult cardiomyocytes and increase their survival
Kubin, T., Ando, H., Scholz, D., Bramlage, P., Sawa Kostin, D., van Veen, A., Heling, A., Hein, S., Fischer, S., Breier, A., et al. (1999) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1999.276.6.h2179 · Cited by 26 · see citing works
Gs, B. (1974) · PubMed · Cited by 21 · see citing works
A genetic based model of cardiac hypertrophy in MLC-ras mice.
Gottshall, K. R., Becker, K., Hunter, J. J., & Chien, K. R. (1996) · PubMed · Cited by 6 · see citing works
A genetic based model of cardiac hypertrophy inMLC-Ras mice
Gottshall, K. R., Becker, K., Hunter, J. J., & Chien, K. R. (1996) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(96)80056-x · Cited by 5 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Entanglement of GSK-3β, β-catenin and TGF-β1 signaling network to regulate myocardial fibrosis
Guo, Y., Gupte, M., Umbarkar, P., Singh, A. P., Sui, J. Y., Force, T. L., & Lal, H. (2017) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2017.07.011 · Cited by 155 · see citing works
Physiologic functions of PP2A: Lessons from genetically modified mice
Reynhout, S., & Janssens, V. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.07.010 · Cited by 124 · see citing works
Roles and regulation of protein phosphatase 2A (PP2A) in the heart
Lubbers, E. R., & Mohler, P. J. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2016.11.003 · Cited by 83 · see citing works
Glycogen synthase kinase-3β: a promising candidate in the fight against fibrosis
Zheng, H., Yang, Z. P., Xin, Z., Yang, Y., Yu, Y., Cui, J., Liu, H., & Chen, F. (2020) · Theranostics · doi:10.7150/thno.47717 · Cited by 80 · see citing works
A Review of Cardiovascular Toxicity of Microcystins
Cao, L., Massey, I. Y., Feng, H., & Yang, F. (2019) · Toxins · doi:10.3390/toxins11090507 · Cited by 65 · see citing works
Challenges and Opportunities for Therapeutic Targeting of Calmodulin Kinase II in Heart
Nassal, D. M., Gratz, D. H., & Hund, T. J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00035 · Cited by 63 · see citing works
Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis
Guo, S. (2018) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12221 · Cited by 58 · see citing works
Xu, L.-L., Su, H.-X., Li, P., & Li, H. (2023) · Nutrients · doi:10.3390/nu15041049 · Cited by 34 · see citing works
Characterization of Stressed Transgenic Mice Overexpressing H2-Histamine Receptors in the Heart
Gergs, U., Kirchhefer, U., Bergmann, F., Künstler, B., Mißlinger, N., Au, B., Mahnkopf, M., Wache, H., & Neumann, J. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000063 · Cited by 30 · see citing works
Role of Protein Phosphatase 2A in Osteoblast Differentiation and Function
Okamura, H., Yoshida, K., Morimoto, H., Teramachi, J., Ochiai, K., Haneji, T., & Yamamoto, A. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6030023 · Cited by 28 · see citing works
Cardiomyocyte specific deletion of PP2A causes cardiac hypertrophy.
Li, L., Fang, C., Xu, D., Xu, Y., Fu, H., & Li, J. (2016) · PubMed Central · Cited by 25 · see citing works
Profiling metabolic remodeling in PP2Acα deficiency and chronic pressure overload mouse hearts
Dong, D., Li, L., Gu, P., Jin, T., Wen, M., Yuan, C., Gao, X., Liu, C., & Zhang, Z. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.10.016 · Cited by 20 · see citing works
Kronenbitter, A. V., Funk, F., Hackert, K., Gorreßen, S., Glaser, D., Boknı́k, P., Poschmann, G., Stühler, K., Isić, M., Krüger, M., et al. (2018) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2018.04.004 · Cited by 18 · see citing works
Protein phosphatase 2A in the healthy and failing heart: New insights and therapeutic opportunities
Sergienko, N. M., Donner, D. G., Delbridge, L. M. D., McMullen, J. R., & Weeks, K. L. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110213 · Cited by 19 · see citing works
Guo, Y., Ran, P., Liu, Q., & Xu, D. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.07.070 · Cited by 17 · see citing works
Wang, B., Zhou, Q., Bi, Y., Zhou, W., Zeng, Q., Liu, Z., Liu, X., & Zhan, Z. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900148 · Cited by 16 · see citing works
Cantharidin increases the force of contraction and protein phosphorylation in isolated human atria
Schwarz, R., Hofmann, B., Gergs, U., & Neumann, J. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02483-9 · Cited by 14 · see citing works
Mechanisms of Systolic Cardiac Dysfunction in PP2A, PP5 and PP2AxPP5 Double Transgenic Mice
Dörner, M.-F., Boknı́k, P., Köpp, F., Buchwalow, I., Neumann, J., & Gergs, U. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179448 · Cited by 14 · see citing works
PP2A regulates SCF-induced cardiac stem cell migration through interaction with p38 MAPK
Wang, Y., Xia, Y., Kuang, D., Duan, Y., & Wang, G. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.10.006 · Cited by 14 · see citing works
Wnt Signaling Pathway: Biological Function, Diseases, and Therapeutic Interventions
Jin, X., Wang, J., Cao, R., & Jiang, D. (2026) · MedComm · doi:10.1002/mco2.70580 · Cited by 14 · see citing works
MicroRNA and receptor mediated signaling pathways as potential therapeutic targets in heart failure
Tuttolomondo, A., Simonetta, I., & Pinto, A. V. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1212017 · Cited by 12 · see citing works
Yang, N., Hou, Y.-B., Cui, T.-H., Yu, J., He, S., & Zhu, H. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s463477 · Cited by 9 · see citing works
Cheng, P., Lian, F.-Z., Wang, X., Cai, G.-W., Huang, G.-Y., Chen, M., Shen, A., & Gao, S. (2019) · BioMed Research International · doi:10.1155/2019/4794082 · Cited by 8 · see citing works
Bollmann, P., Werner, F., Jaron, M., Bruns, T. A., Wache, H., Runte, J., Boknı́k, P., Kirchhefer, U., Müller, F. U., Buchwalow, I., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.591773 · Cited by 7 · see citing works
Targeting PP2A in cancer: an underrated option
Sarais, F., Krempien, F., Koehn, C., Brewing, L., Classen, C. F., Walter, M., & Shokraie, O. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03560-y · Cited by 8 · see citing works
Protein Phosphatase Signaling in Cardiac Myocytes
Abdallah, D., Malhotra, N., & Refaey, M. E. (2022) · Springer eBooks · doi:10.1007/978-3-031-08309-9_5 · Cited by 6 · see citing works
Protein Phosphatase 2A as a Therapeutic Target in Pulmonary Diseases
Yu, H. K. Y., Zaveri, S., Sattar, Z., Schaible, M., Gandara, B. P., Uddin, A., McGarvey, L. R., Ohlmeyer, M. H. J., & Geraghty, P. M. (2023) · Medicina · doi:10.3390/medicina59091552 · Cited by 5 · see citing works
Gergs, U., Wackerhagen, S., Fuhrmann, T., Schäfer, I., & Neumann, J. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-02973-4 · Cited by 4 · see citing works
Protein Phosphatase 2A Improves Cardiac Functional Response to Ischemia and Sepsis
Gergs, U., Jahn, T., Schulz, N., Großmann, C., Rueckschloss, U., Demus, U., Buchwalow, I., & Neumann, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094688 · Cited by 4 · see citing works
Herting, J. R., Berg, A. M., Hadová, K., Heinick, A., König, S., Kuhlmann, M. T., Müller, F. U., & Kirchhefer, U. (2022) · Journal of Molecular and Cellular Cardiology Plus · doi:10.1016/j.jmccpl.2022.100030 · Cited by 3 · see citing works
Zhang, C., Qiu, X., Shi, W., & Zhu, S. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1645868 · Cited by 2 · see citing works
Sergienko, N. M., Trewin, A. J., Kiriazis, H., Raaijmakers, A. J. A., Donner, D. G., Garside, V. C., Smith, K., Bell, J. R., Mellor, K. M., Delbridge, L. M. D., et al. (2024) · npj Metabolic Health and Disease · doi:10.1038/s44324-024-00033-2 · Cited by 2 · see citing works
Tang, S., Liu, Y., Wang, X., Liang, Z., Cai, H., Mo, L., Xiao, D., Guo, S., Ouyang, Y., Sun, B., et al. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.10.093 · Cited by 1 · see citing works
Identification of a survival associated gene trio in chemical induced breast cancer
Ganaie, I. A., Malik, M. Z., Mangangcha, I. R., Jain, S. K., & Wajid, S. (2023) · Biochimie · doi:10.1016/j.biochi.2023.01.003 · Cited by 1 · see citing works
LIGAÇÃO DA ARTÉRIA CORONÁRIA ESQUERDA: UMA TÉCNICA DE ESTUDO DAS ALTERAÇÕES ISQUÊMICAS DO MIOCÁRDIO
Rodrigues, F. A., Pimenta, V. D. S. C., & de Araújo, E. G. (2016) · Enciclopédia Biosfera · doi:10.18677/enciclopedia_biosfera_2016_062
Protein Phosphatase 2A Orchestrates Mitochondrial Dynamics via MAPK Signaling in heartPreprint
Dong, D., Zhang, Y., Li, L., Fan, H., Jin, T., Gao, X., & Zhang, Z. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.26.708402
Protein phosphatase 2A impairs cardiac uptake of glucose in the mammalian heart
Hadová, K., Gündel, D., Knieß, T., Brust, P., Klimas, J., Neumann, J., & Gergs, U. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05617-x
Mechanisms of systolic heart failure in PP2CxPP5 double transgenic mice
Schwarz, R., Hadová, K., Klimas, J., Buchwalow, I., Neumann, J., & Gergs, U. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05671-5
- Authors
- Hoehn, M., Zhang, Y., Xu, J., Gergs, U., Boknik, P., Werdan, K., Neumann, J., & Ebelt, H.
- Affiliations
- Martin Luther University Halle-Wittenberg (DE)
- Corresponding author
- Ebelt, H.
- Venue
- International Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 2015-03
- Volume
- 183
- Pages
- 39-46
- ISSN
- 0167-5273 (ISSN-L)
- OpenAlex
- W1992840448
- Cited by
- 38
- References
- 49
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 3 · 2017: 4 · 2016: 5 · 2015: 1
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Keywords
- protein phosphatase 2A, chronic myocardial infarction, cardiac remodeling, β-catenin, glycogen synthase kinase-3β, Akt signaling, dilated cardiomyopathy, cardiomyocyte hypertrophy, myocardial fibrosis, SERCA, CaMKIIα, heart failure, transgenic mice
- MeSH terms
- Glycogen Synthase Kinase 3 beta, Animals, Cardiomyopathy, Dilated, Cardiomyopathy, Hypertrophic, Electrocardiography, Male, Mice, Transgenic, Myocardial Infarction, Blotting, Western, Gene Expression, Glycogen Synthase Kinase 3, beta Catenin, Mice, Protein Phosphatase 2, Atrial Remodeling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review